Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Business Insurance: “Drug Formularies Not a Top Legislative Priority this Year”
News Release
Business Insurance: “Drug Formularies Not a Top Legislative Priority this Year”
Workers' Comp
News Release
Enlyte Publishes 2022 Workers’ Compensation Technology Trends Report
SAN DIEGO—Enlyte, the parent brand of Mitchell, Genex and Coventry, today released survey results of its
Workers' Comp
Article
High Dollar Claims Driving Workers’ Compensation COVID-19 Claims Costs
Data analysis by Aarthi Thiruvengadam.
Mitchell
News Release
Symbicort Generic Approval on March 15, 2022
Recently the U.S.
Workers' Comp
Article
High Dollar Claims Driving Workers’ Compensation COVID-19 Claims Costs
Data analysis by Aarthi Thiruvengadam.
Disability
Article
Ticket to Work
We all have bad days at work when we dream about how nice it would be to not have to earn a paycheck. But how long would we be happy?